Former Be Bio chief Joanne Smith-Farrell appointed CEO of Orbis Medicines as Enanta CEO Jay Luly announces retirement
read at Endpoints ↗Neutral
Former Be Bio Pharmaceuticals CEO Joanne Smith-Farrell has joined Orbis Medicines as its new chief executive.
Orbis, a startup backed by Eli Lilly and Novo Nordisk, focuses on developing oral macrocycle drugs.
Smith-Farrell replaces co‑founder Morten Graugaard, who stepped down from the CEO role.
In a separate leadership change, Enanta Pharmaceuticals announced that its long‑time chief executive Jay Luly will retire.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “After Be Bio shutdown, its CEO heads to Orbis; Enanta's longtime chief Jay Luly to retire”
read at Endpoints ↗96 words · retrieved 33m ago
comments(0)
5-min edit window · permanent after that